However, sensitivity of FIT for CRC at thresholds of 10–150 μg Hb/g translate in a symptomatic population to negative predictive values that are unacceptable; hence, FIT-negative symptomatic patients will still require colonoscopy. The gene discussed is GSTM1; the disease is colorectal carcinoma.